These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 24106478)

  • 1. Integrative EEG biomarkers predict progression to Alzheimer's disease at the MCI stage.
    Poil SS; de Haan W; van der Flier WM; Mansvelder HD; Scheltens P; Linkenkaer-Hansen K
    Front Aging Neurosci; 2013; 5():58. PubMed ID: 24106478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural biomarker diagnosis and prediction to mild cognitive impairment and Alzheimer's disease using EEG technology.
    Jiao B; Li R; Zhou H; Qing K; Liu H; Pan H; Lei Y; Fu W; Wang X; Xiao X; Liu X; Yang Q; Liao X; Zhou Y; Fang L; Dong Y; Yang Y; Jiang H; Huang S; Shen L
    Alzheimers Res Ther; 2023 Feb; 15(1):32. PubMed ID: 36765411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The I.F.A.S.T. model allows the prediction of conversion to Alzheimer disease in patients with mild cognitive impairment with high degree of accuracy.
    Buscema M; Grossi E; Capriotti M; Babiloni C; Rossini P
    Curr Alzheimer Res; 2010 Mar; 7(2):173-87. PubMed ID: 19860726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity of EEG Dynamics for Early Diagnosis of Alzheimer's Disease Using Permutation Entropy Neuromarker.
    Şeker M; Özbek Y; Yener G; Özerdem MS
    Comput Methods Programs Biomed; 2021 Jul; 206():106116. PubMed ID: 33957376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMS-EEG Biomarkers of Amnestic Mild Cognitive Impairment Due to Alzheimer's Disease: A Proof-of-Concept Six Years Prospective Study.
    Ferreri F; Guerra A; Vollero L; Ponzo D; Määtta S; Könönen M; Vecchio F; Pasqualetti P; Miraglia F; Simonelli I; Corbetta M; Rossini PM
    Front Aging Neurosci; 2021; 13():737281. PubMed ID: 34880743
    [No Abstract]   [Full Text] [Related]  

  • 6. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Alzheimers Res Ther; 2020 Jul; 12(1):82. PubMed ID: 32641111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer's disease created by integrative analysis of multi-omics data.
    Shigemizu D; Akiyama S; Higaki S; Sugimoto T; Sakurai T; Boroevich KA; Sharma A; Tsunoda T; Ochiya T; Niida S; Ozaki K
    Alzheimers Res Ther; 2020 Nov; 12(1):145. PubMed ID: 33172501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
    Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
    Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting-state electroencephalographic biomarkers of Alzheimer's disease.
    Cecchetti G; Agosta F; Basaia S; Cividini C; Cursi M; Santangelo R; Caso F; Minicucci F; Magnani G; Filippi M
    Neuroimage Clin; 2021; 31():102711. PubMed ID: 34098525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlangen Score as a tool to predict progression from mild cognitive impairment to dementia in Alzheimer's disease.
    Baldeiras I; Santana I; Leitão MJ; Vieira D; Duro D; Mroczko B; Kornhuber J; Lewczuk P
    Alzheimers Res Ther; 2019 Jan; 11(1):2. PubMed ID: 30611311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the fluctuations of dynamic resting-state electrophysiological functional connectivity: reduced neuronal coupling variability in mild cognitive impairment and dementia due to Alzheimer's disease.
    Núñez P; Poza J; Gómez C; Rodríguez-González V; Hillebrand A; Tola-Arribas MA; Cano M; Hornero R
    J Neural Eng; 2019 Sep; 16(5):056030. PubMed ID: 31112938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal classification of Alzheimer's disease and mild cognitive impairment.
    Zhang D; Wang Y; Zhou L; Yuan H; Shen D;
    Neuroimage; 2011 Apr; 55(3):856-67. PubMed ID: 21236349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.
    Dickerson BC; Wolk DA;
    Front Aging Neurosci; 2013; 5():55. PubMed ID: 24130528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative Frequency Power of EEG Correlates with Progression of Mild Cognitive Impairment to Dementia in Parkinson's Disease.
    Gu Y; Chen J; Lu Y; Pan S
    Clin EEG Neurosci; 2016 Apr; 47(2):113-7. PubMed ID: 25519446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction.
    Hatashita S; Yamasaki H
    PLoS One; 2013; 8(6):e66877. PubMed ID: 23799136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.